Lixte Biotechnology Holdings Inc.(LIXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LIXT Lixte Biotechnology Holdings Inc.

Pre-Mkt 06-29 08:55:49 EDT

7.19

+0.54

+8.12%

盘前7.48

+0.29+4.03%

08:29 EDT

High7.19	Low6.67	Vol214.07K
Open6.67	D1 Closing6.65	Amplitude7.82%
Mkt Cap125.01M	Tradable Cap81.60M	Total Shares17.39M
T/O1.50M	T/O Rate1.89%	Tradable Shares11.35M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LIXT","market":"US","secType":"STK","nameCN":"Lixte Biotechnology Holdings Inc.","latestPrice":7.19,"timestamp":1782504000000,"preClose":6.65,"halted":0,"volume":214074,"hourTrading":{"tag":"盘前","latestPrice":7.48,"preClose":7.19,"latestTime":"08:29 EDT","volume":709,"amount":5328.5700424,"timestamp":1782736147345,"change":0.29,"changeRate":0.040334,"amplitude":0.013561},"delay":0,"changeRate":0.081203007518797,"floatShares":11348704,"shares":17386500,"eps":-1.15,"marketStatus":"Pre-Mkt","change":0.54,"latestTime":"06-29 08:55:49 EDT","open":6.67,"high":7.19,"low":6.67,"amount":1502687.305224,"amplitude":0.078195,"askPrice":7.97,"askSize":10,"bidPrice":7.09,"bidSize":16,"shortable":3,"etf":0,"ttmEps":-1.15,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782739800000},"marketStatusCode":1,"adr":0,"listingDate":1606280400000,"exchange":"NASDAQ","adjPreClose":7.19,"preHourTrading":{"tag":"盘前","latestPrice":7.48,"preClose":7.19,"latestTime":"08:29 EDT","volume":709,"amount":5328.5700424,"timestamp":1782736147345,"change":0.29,"changeRate":0.040334,"amplitude":0.013561},"postHourTrading":{"tag":"盘后","latestPrice":7.13,"preClose":7.19,"latestTime":"18:11 EDT","volume":7175,"amount":51266.7894,"timestamp":1782511893238,"change":-0.06,"changeRate":-0.008345,"amplitude":0.002782},"volumeRatio":0.42944888667057024},"requestUrl":"/m/hq/s/LIXT","defaultTab":"news","newsList":[{"id":"2646935718","title":"Lixte Biotechnology announces inclusion in Russell Microcap Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2646935718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646935718?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:35","pubTimestamp":1782477325,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology (LIXT) announced its inclusion in the Russell Microcap Index, effective after the close of the U.S. equity markets on June 26 a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lixte-biotechnology-announces-inclusion-in-russell-microcap-index-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lixte-biotechnology-announces-inclusion-in-russell-microcap-index-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646357340","title":"Lixte Joins Russell Microcap Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2646357340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646357340?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:30","pubTimestamp":1782477005,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nFWN42Y0A7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644031101","title":"Lixte Advances NOMAD Acquisition, Pivoting to Power Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2644031101","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644031101?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:37","pubTimestamp":1781818642,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings ( ($LIXT) ) has provided an update. On June 17, 2026, Lixte Biotechnology issued a $6.5 million secured promissory not...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lixte-advances-nomad-acquisition-pivoting-to-power-solutions-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lixte-advances-nomad-acquisition-pivoting-to-power-solutions-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LIXT","BK4084","PW","BK4234"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644608639","title":"Lixte Biotechnology provides update on NOMAD acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2644608639","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644608639?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:53","pubTimestamp":1781787191,"startTime":"0","endTime":"0","summary":"LIXTE Biotechnology (LIXT) provided an update on its previously announced definitive agreement to acquire 100% of NOMAD Transportable Power Systems...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lixte-biotechnology-provides-update-on-nomad-acquisition-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lixte-biotechnology-provides-update-on-nomad-acquisition-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644008588","title":"Lixte Biotechnology expects NOMAD acquisition to close around July 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2644008588","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644008588?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:30","pubTimestamp":1781785849,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology plans to buy 100% of NOMAD Transportable Power Systems, targeting a close on or about July 1, 2026.USD 6.5 million pre-closing loan to NOMAD to fund long-lead components, support working capital, and help convert backlog into deliveries.Post-close, the combined company is set to be renamed NOMAD Power Solutions and trade on Nasdaq under a new ticker.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL1gnSbD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BN0W2T93.GBP","BK4139","SG9999014005.SGD","LIXT","BK4588","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2W23.USD","NDAQ","LU2095319765.USD","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","IE00BKPKM429.USD","BK4112","IE00BN0W2V16.EUR","BK4585","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644083078","title":"Lixte Biotechnology Provides Update on Nomad Acquisition; Transaction Expected to Close on or About July 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2644083078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644083078?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:30","pubTimestamp":1781785800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nTUA5DNTMH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644793837","title":"Lixte Biotechnology Pivoting to Nomad Power Solutions Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2644793837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644793837?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:10","pubTimestamp":1781644210,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings ( ($LIXT) ) has shared an announcement. On June 11, 2026, Lixte Biotechnology Holdings, Inc. signed a definitive agree...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lixte-biotechnology-pivoting-to-nomad-power-solutions-merger?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lixte-biotechnology-pivoting-to-nomad-power-solutions-merger?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NOMD","BK4139","LU2211817866.USD","BK4234","LU1169589451.USD","BK4084","LU1989763690.USD","LU1169590202.USD","PW","LU1989763427.SGD","LIXT","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644767439","title":"Lixte Biotechnology agrees to acquire mobile battery storage provider NOMAD Transportable Power Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2644767439","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644767439?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:01","pubTimestamp":1781640073,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology entered a definitive agreement on June 12, 2026 to acquire 100% of NOMAD Transportable Power Systems.Deal shifts the business toward mobile, utility-grade battery energy storage systems; NOMAD markets a transportable 1 MW platform.Combined company is expected to be renamed NOMAD Power Solutions following closing, subject to required approvals.NOMAD reported about 175% revenue growth in 2025; management projected about 135% growth in 2026.NOMAD cited more than 30 active customer opportunities across North America, with roughly 75% of sales activity inbound.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lixte Biotechnology Holdings Inc. published the original content used to generate this news brief via EDGAR, the El","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL8k37QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643417292","title":"Lixte Biotechnology Shares Down on Plans for Nomad Transportable Power Deal, Name Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2643417292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643417292?lang=en_us&edition=fundamental","pubTime":"2026-06-13 01:48","pubTimestamp":1781286480,"startTime":"0","endTime":"0","summary":"Shares of Lixte Biotechnology Holdings declined after it announced plans to buy battery energy company Nomad Transportable Power Systems and change Lixte's name to Nomad Power Solutions.The stock was down 12% to $6.41 in Friday afternoon trading. Shares are up 63% this year.Cancer-drug developer Lixte said June 1 that it would transform into an AI energy infrastructure equipment and services business, and seek a strategic acquisition partner for its pharmaceutical and medical technology operations.Lixte didn't disclose a deal price for Nomad. The company said Nomad's revenue rose about 175% in 2025. Lixte said Nomad's mobile utility-grade battery energy storage systems have a structural permitting and deployment advantage, offering an alternative to permanent BESS projects that \"routinely face development timelines of two to five years or longer.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","LU1169590202.USD","BK4234","LU1989763690.USD","PW","BK4084","BK4139","LU2211817866.USD","LIXT","LU1989763427.SGD","NOMD","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197569717","title":"From Oncology Drug Development to Power Infrastructure: Nasdaq-Listed LIXTE Bio Pivots to Target AI Energy Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1197569717","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197569717?lang=en_us&edition=fundamental","pubTime":"2026-06-12 21:44","pubTimestamp":1781271863,"startTime":"0","endTime":"0","summary":"One of the most striking corporate transformations of 2026 is reshaping a clinical-stage biotech firm into a power infrastructure company, directly targeting the electricity shortages constraining...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642293873","title":"BUZZ-LIXTE to buy battery firm NOMAD, shifts away from cancer drugs; shares rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2642293873","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642293873?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:42","pubTimestamp":1781268156,"startTime":"0","endTime":"0","summary":"BUZZ-LIXTE to buy battery firm NOMAD, shifts away from cancer drugs; shares rise** Shares of LIXTE Biotechnology Holdings LIXT.O rise 5.8% to $7.67 premarket** LIXT says it will acquire NOMAD Transportable Power Systems, which makes portable battery units supplying electricity where grid access is limited** Says NOMAD's systems can deliver up to 1 megawatt of power and be deployed quickly, avoiding delays tied to permanent installations** Financial terms of the deal not disclosed** LIXT to rename itself NOMAD Power Solutions after the deal closes, shifting away from cancer drug development** NOMAD saw 175% revenue growth in 2025 and expects another 135% rise in 2026; NOMAD CEO says deal will aid manufacturing expansion** The combined company will focus on mobile, utility-scale battery storage systems** As of last close, LIXT stock up ~84% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nL4N42K0WJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642269298","title":"Lixte Biotechnology agrees to buy NOMAD Transportable Power Systems, plans rebrand to NOMAD Power Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2642269298","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642269298?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:30","pubTimestamp":1781267446,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology entered a definitive agreement to acquire 100% of NOMAD Transportable Power Systems, a provider of mobile, utility-grade battery energy storage systems.NOMAD markets a transportable 1 MW BESS designed to meet utility safety and interconnection standards, positioning it for utility and large industrial customers.On closing, Lixte plans to rename the company NOMAD Power Solutions; any ticker change is expected in a later announcement.NOMAD reported revenue growth of about 175% in 2025; management projects about 135% growth in 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL2Pzys4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BN0W2T93.GBP","BK4585","IE00B64PRP62.GBP","LU2095319765.USD","IE00BGHQF748.EUR","BK4139","BK4112","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4588","SG9999014039.USD","LU2210149790.SGD","LIXT","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014021.USD","SG9999014013.SGD","LU0314104364.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642329847","title":"Lixte Biotechnology to Acquire Nomad Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (Bess)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642329847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642329847?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:30","pubTimestamp":1781267400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nTUA6XVMGP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641107198","title":"Lixte Biotechnology Announces At-the-Market Equity Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641107198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641107198?lang=en_us&edition=fundamental","pubTime":"2026-06-05 07:07","pubTimestamp":1780614450,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings ( ($LIXT) ) just unveiled an announcement. On June 2, 2026, Lixte Biotechnology Holdings, Inc. entered into a securiti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lixte-biotechnology-announces-at-the-market-equity-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lixte-biotechnology-announces-at-the-market-equity-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LIXT","EQR","BK4588","BK4215","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640027839","title":"Lixte Biotechnology Prices $16.6 Million Registered Direct Offering Priced at the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2640027839","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640027839?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:19","pubTimestamp":1780492768,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology  has agreed with accredited investors for a registered direct offering of $16.6 million of shares and pre-funded warrants, the company said Wednesday.The offering includes 2.63 million common shares and pre-funded warrants priced at $6.31 per share, it said.The entire deal was priced at the market, the company said.Lixte said it will use net proceeds, together with existing cash, for general corporate purposes, working capital and strategic initiatives.The deal is expected to close on or about Wednesday.Shares of the company were 3.7% higher in recent Wednesday premarket trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640549904","title":"Lixte Biotechnology prices USD 16.57 million registered direct offering at USD 6.31/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2640549904","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640549904?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:31","pubTimestamp":1780489877,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology Holdings launched a registered direct offering targeting USD 16.57 million, priced at-the-market under Nasdaq rules.Deal set at USD 6.31 per common share; includes pre-funded warrants priced at USD 6.3099 with a USD 0.0001 exercise price.Offering covers 2,625,362 shares of common stock plus pre-funded warrants exercisable for one share each.Gross proceeds expected to be about USD 16.57 million; closing expected on or about June 3, 2026.Proceeds earmarked for general corporate purposes, working capital, and strategic initiatives.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lixte Biotechnology Holdings Inc. published the original content used to generate this news brief on June 03, 2026, and is solely responsible f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL52Mcpm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904371","title":"Lixte Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904371?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:30","pubTimestamp":1780489802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA8WKKT8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640964887","title":"Lixte Biotechnology director Stuart D. Porter files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640964887","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640964887?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:01","pubTimestamp":1780344060,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology filed an initial beneficial ownership statement for director Stuart D. Porter, dated May 29, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lixte Biotechnology Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL6qQZvp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640952735","title":"Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2640952735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640952735?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:40","pubTimestamp":1780321247,"startTime":"0","endTime":"0","summary":"An update from Lixte Biotechnology Holdings ( ($LIXT) ) is now available. On May 29, 2026, Lixte Biotechnology’s board appointed veteran energy inv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lixte-biotechnology-shifts-strategy-to-ai-energy-infrastructure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lixte-biotechnology-shifts-strategy-to-ai-energy-infrastructure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIX","LIXT","ARTY","AIPO","BK4139","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640954304","title":"Lixte names Denham Capital founder Stuart Porter to board amid strategic shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2640954304","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640954304?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:50","pubTimestamp":1780318220,"startTime":"0","endTime":"0","summary":"Lixte Biotechnology named Denham Capital founder Stuart D. Porter to its board, effective today.Porter is Denham’s founder, managing partner, CEO, chief investment officer; oversaw more than $12 billion across energy, energy-transition investments.Board addition aligns with Lixte’s shift toward AI power infrastructure equipment and services for data centers.Denham’s infrastructure group is advancing about 10 GW of AI data-center-oriented power generation opportunities in the US and Europe.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLX0dMJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BN0W2T93.GBP","BK4585","IE00B64PRP62.GBP","LU2095319765.USD","IE00BGHQF748.EUR","BK4139","BK4112","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4588","SG9999014039.USD","LU2210149790.SGD","LIXT","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014021.USD","SG9999014013.SGD","LU0314104364.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lixte.com","stockEarnings":[{"period":"1week","weight":-0.0552},{"period":"1month","weight":0.1199},{"period":"3month","weight":1.3269},{"period":"6month","weight":0.7666},{"period":"1year","weight":8.3377},{"period":"ytd","weight":0.8295}],"compareEarnings":[{"period":"1week","weight":-0.0238},{"period":"1month","weight":-0.0286},{"period":"3month","weight":0.1497},{"period":"6month","weight":0.056},{"period":"1year","weight":0.1914},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"LIXTE Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colon cancer. The company's Phase 1b portion of its advanced soft tissue sarcoma clinical trial seeks to determine appropriate dosing and toxicity for treating soft tissue sarcomas with combination of LB-100 and standard-of-care chemotherapy; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.153774},{"month":2,"riseRate":0.625,"avgChangeRate":0.06495},{"month":3,"riseRate":0.5,"avgChangeRate":-0.03366},{"month":4,"riseRate":0.375,"avgChangeRate":-0.074412},{"month":5,"riseRate":0.444444,"avgChangeRate":0.082784},{"month":6,"riseRate":0.555556,"avgChangeRate":0.044413},{"month":7,"riseRate":0.625,"avgChangeRate":0.400968},{"month":8,"riseRate":0.5,"avgChangeRate":0.097631},{"month":9,"riseRate":0.375,"avgChangeRate":0.00973},{"month":10,"riseRate":0.375,"avgChangeRate":-0.019298},{"month":11,"riseRate":0.375,"avgChangeRate":-0.035386},{"month":12,"riseRate":0.25,"avgChangeRate":-0.145393}],"exchange":"NASDAQ","name":"Lixte Biotechnology Holdings Inc.","nameEN":"Lixte Biotechnology Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lixte Biotechnology Holdings Inc.(LIXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Lixte Biotechnology Holdings Inc.(LIXT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Lixte Biotechnology Holdings Inc.,LIXT,Lixte Biotechnology Holdings Inc.股票,Lixte Biotechnology Holdings Inc.股票老虎,Lixte Biotechnology Holdings Inc.股票老虎国际,Lixte Biotechnology Holdings Inc.行情,Lixte Biotechnology Holdings Inc.股票行情,Lixte Biotechnology Holdings Inc.股价,Lixte Biotechnology Holdings Inc.股市,Lixte Biotechnology Holdings Inc.股票价格,Lixte Biotechnology Holdings Inc.股票交易,Lixte Biotechnology Holdings Inc.股票购买,Lixte Biotechnology Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lixte Biotechnology Holdings Inc.(LIXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Lixte Biotechnology Holdings Inc.(LIXT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}